IPO registrations (S-1, F-1) · Registrants
Nuwellis, Inc.
- SEC CIK
- 1506492 · filings on EDGAR ↗
- Former names
- CHF Solutions, Inc. (2017–2021); Sunshine Heart, Inc. (2010–2017)
- Registration
- Form S-1, first filed 2012-07-17, last 2026-06-04; 19 initial registrations, 38 amendments
- Outcome
- Final prospectus filed 2012-08-10; declared effective 2012-08-09
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- DE
- Business address
- 12988 VALLEY VIEW ROAD, Eden Prairie, MN 55344
- EIN
- 68-0533453
- Ticker
- NUWE (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Nuwellis, Inc. on the corporate pages
On this site
- Business registration: NUWELLIS, INC EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Nuwellis, Inc. Fuzzy (name and state)
- Form 5500 plan sponsor: NUWELLIS, INC. EXACT (EIN (EXACT))
- Federal award recipient: NUWELLIS INC Fuzzy (name and state)
- Form D issuer: Nuwellis, Inc. EXACT (CIK (EXACT))
- SEC filer: CHF Solutions, Inc. EXACT (CIK (EXACT))
- Person page: Warren S Watson Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 115
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2012-07-17 | S-1 | S-1 (registration) | Sunshine Heart, Inc. | 0001047469-12-007239 ↗ |
| 2012-07-30 | S-1/A | S-1/A (amendment) | Sunshine Heart, Inc. | 0001047469-12-007519 ↗ |
| 2012-08-01 | S-1/A | S-1/A (amendment) | Sunshine Heart, Inc. | 0001047469-12-007611 ↗ |
| 2012-08-08 | S-1/A | S-1/A (amendment) | Sunshine Heart, Inc. | 0001047469-12-007914 ↗ |
| 2012-08-09 | S-1MEF | S-1MEF (added securities) | Sunshine Heart, Inc. | 0001104659-12-056697 ↗ |
| 2012-08-09 | EFFECT | EFFECT (declared effective) | Sunshine Heart, Inc. | 9999999995-12-002429 ↗ |
| 2012-08-10 | 424B4 | 424B4 (final prospectus) | Sunshine Heart, Inc. | 0001047469-12-008107 ↗ |
| 2013-01-28 | S-1 | S-1 (registration) | Sunshine Heart, Inc. | 0001104659-13-005229 ↗ |
| 2013-02-08 | S-1/A | S-1/A (amendment) | Sunshine Heart, Inc. | 0001104659-13-008886 ↗ |
| 2013-02-13 | S-1/A | S-1/A (amendment) | Sunshine Heart, Inc. | 0001104659-13-009856 ↗ |
| 2013-02-13 | EFFECT | EFFECT (declared effective) | Sunshine Heart, Inc. | 9999999995-13-000495 ↗ |
| 2013-04-05 | EFFECT | EFFECT (declared effective) | Sunshine Heart, Inc. | 9999999995-13-000903 ↗ |
| 2014-05-05 | EFFECT | EFFECT (declared effective) | Sunshine Heart, Inc. | 9999999995-14-001335 ↗ |
| 2014-06-05 | EFFECT | EFFECT (declared effective) | Sunshine Heart, Inc. | 9999999995-14-001675 ↗ |
| 2016-12-15 | S-1 | S-1 (registration) | Sunshine Heart, Inc. | 0001104659-16-162310 ↗ |
| 2016-12-30 | EFFECT | EFFECT (declared effective) | Sunshine Heart, Inc. | 9999999995-17-000010 ↗ |
| 2017-02-14 | S-1 | S-1 (registration) | Sunshine Heart, Inc. | 0001104659-17-009236 ↗ |
| 2017-03-15 | S-1/A | S-1/A (amendment) | Sunshine Heart, Inc. | 0001104659-17-016668 ↗ |
| 2017-03-21 | S-1 | S-1 (registration) | Sunshine Heart, Inc. | 0001047469-17-001806 ↗ |
| 2017-03-21 | EFFECT | EFFECT (declared effective) | Sunshine Heart, Inc. | 9999999995-17-000608 ↗ |
| 2017-03-29 | S-1/A | S-1/A (amendment) | Sunshine Heart, Inc. | 0001047469-17-002100 ↗ |
| 2017-04-05 | S-1/A | S-1/A (amendment) | Sunshine Heart, Inc. | 0001047469-17-002343 ↗ |
| 2017-04-06 | S-1/A | S-1/A (amendment) | Sunshine Heart, Inc. | 0001047469-17-002386 ↗ |
| 2017-04-18 | EFFECT | EFFECT (declared effective) | Sunshine Heart, Inc. | 9999999995-17-000861 ↗ |
| 2017-04-19 | 424B4 | 424B4 (final prospectus) | Sunshine Heart, Inc. | 0001047469-17-002734 ↗ |
| 2017-10-18 | S-1 | S-1 (registration) | CHF Solutions, Inc. | 0001567619-17-002211 ↗ |
| 2017-11-06 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001567619-17-002315 ↗ |
| 2017-11-13 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001567619-17-002333 ↗ |
| 2017-11-17 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001567619-17-002350 ↗ |
| 2017-11-20 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001567619-17-002370 ↗ |
| 2017-11-21 | EFFECT | EFFECT (declared effective) | CHF Solutions, Inc. | 9999999995-17-003043 ↗ |
| 2017-11-22 | S-1MEF | S-1MEF (added securities) | CHF Solutions, Inc. | 0001567619-17-002378 ↗ |
| 2017-11-22 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001567619-17-002382 ↗ |
| 2018-05-23 | EFFECT | EFFECT (declared effective) | CHF Solutions, Inc. | 9999999995-18-001325 ↗ |
| 2018-07-03 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-18-031155 ↗ |
| 2018-12-31 | S-1 | S-1 (registration) | CHF Solutions, Inc. | 0001140361-18-046154 ↗ |
| 2019-01-22 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001140361-19-001295 ↗ |
| 2019-02-25 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001140361-19-003726 ↗ |
| 2019-03-07 | S-1MEF | S-1MEF (added securities) | CHF Solutions, Inc. | 0001140361-19-004549 ↗ |
| 2019-03-07 | EFFECT | EFFECT (declared effective) | CHF Solutions, Inc. | 9999999995-19-000392 ↗ |
| 2019-03-08 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-19-004624 ↗ |
| 2019-03-13 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-19-004860 ↗ |
| 2019-10-25 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-19-019078 ↗ |
| 2019-11-07 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-19-020047 ↗ |
| 2019-12-06 | S-1 | S-1 (registration) | CHF Solutions, Inc. | 0001140361-19-022036 ↗ |
| 2019-12-20 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001140361-19-023010 ↗ |
| 2019-12-20 | S-1 | S-1 (registration) | CHF Solutions, Inc. | 0001140361-19-023012 ↗ |
| 2019-12-27 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001140361-19-023358 ↗ |
| 2019-12-30 | EFFECT | EFFECT (declared effective) | CHF Solutions, Inc. | 9999999995-19-002958 ↗ |
| 2020-01-06 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001140361-20-000240 ↗ |
| 2020-01-23 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001140361-20-001292 ↗ |
| 2020-01-23 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001140361-20-001351 ↗ |
| 2020-01-24 | S-1MEF | S-1MEF (added securities) | CHF Solutions, Inc. | 0001140361-20-001390 ↗ |
| 2020-01-24 | EFFECT | EFFECT (declared effective) | CHF Solutions, Inc. | 9999999995-20-000154 ↗ |
| 2020-01-27 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-20-001446 ↗ |
| 2020-01-29 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-20-001618 ↗ |
| 2020-03-24 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-20-006733 ↗ |
| 2020-03-24 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-20-006741 ↗ |
| 2020-04-29 | S-1 | S-1 (registration) | CHF Solutions, Inc. | 0001140361-20-010167 ↗ |
| 2020-05-06 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001140361-20-010743 ↗ |
| 2020-05-08 | EFFECT | EFFECT (declared effective) | CHF Solutions, Inc. | 9999999995-20-001099 ↗ |
| 2020-05-29 | S-1 | S-1 (registration) | CHF Solutions, Inc. | 0001140361-20-012734 ↗ |
| 2020-06-08 | EFFECT | EFFECT (declared effective) | CHF Solutions, Inc. | 9999999995-20-001371 ↗ |
| 2020-08-06 | S-1 | S-1 (registration) | CHF Solutions, Inc. | 0001140361-20-017622 ↗ |
| 2020-08-17 | S-1/A | S-1/A (amendment) | CHF Solutions, Inc. | 0001140361-20-018541 ↗ |
| 2020-08-18 | EFFECT | EFFECT (declared effective) | CHF Solutions, Inc. | 9999999995-20-002187 ↗ |
| 2020-08-19 | 424B4 | 424B4 (final prospectus) | CHF Solutions, Inc. | 0001140361-20-018754 ↗ |
| 2021-07-02 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-21-002642 ↗ |
| 2021-09-03 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-21-030398 ↗ |
| 2021-09-03 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-21-030399 ↗ |
| 2021-09-20 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-21-031824 ↗ |
| 2021-09-20 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-21-031825 ↗ |
| 2022-09-09 | S-1 | S-1 (registration) | Nuwellis, Inc. | 0001140361-22-032938 ↗ |
| 2022-09-30 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-22-035285 ↗ |
| 2022-10-06 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-22-036448 ↗ |
| 2022-10-11 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-22-036831 ↗ |
| 2022-10-12 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-22-036901 ↗ |
| 2022-10-13 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-22-036980 ↗ |
| 2022-10-13 | S-1MEF | S-1MEF (added securities) | Nuwellis, Inc. | 0001140361-22-037117 ↗ |
| 2022-10-13 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-22-003033 ↗ |
| 2022-10-17 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-22-037255 ↗ |
| 2022-10-17 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-22-037391 ↗ |
| 2022-10-18 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-22-037640 ↗ |
| 2022-10-18 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-22-037644 ↗ |
| 2023-09-21 | S-1 | S-1 (registration) | Nuwellis, Inc. | 0001140361-23-044639 ↗ |
| 2023-09-29 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-23-045868 ↗ |
| 2023-09-29 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-23-002907 ↗ |
| 2023-10-16 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-23-048227 ↗ |
| 2024-01-18 | S-1 | S-1 (registration) | Nuwellis, Inc. | 0001140361-24-002619 ↗ |
| 2024-01-31 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-24-004664 ↗ |
| 2024-02-05 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-24-005711 ↗ |
| 2024-02-08 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-24-006462 ↗ |
| 2024-03-13 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-24-012922 ↗ |
| 2024-04-17 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-24-020212 ↗ |
| 2024-04-26 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-24-001148 ↗ |
| 2024-04-29 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-24-023072 ↗ |
| 2024-07-09 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-24-002111 ↗ |
| 2024-08-15 | S-1 | S-1 (registration) | Nuwellis, Inc. | 0001140361-24-037382 ↗ |
| 2024-08-29 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-24-039018 ↗ |
| 2024-09-06 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-24-002740 ↗ |
| 2024-11-15 | S-1 | S-1 (registration) | Nuwellis, Inc. | 0001140361-24-047089 ↗ |
| 2024-12-19 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-24-049969 ↗ |
| 2024-12-20 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-24-003884 ↗ |
| 2025-05-30 | S-1 | S-1 (registration) | Nuwellis, Inc. | 0001140361-25-020878 ↗ |
| 2025-06-03 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-25-021187 ↗ |
| 2025-06-09 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-25-001872 ↗ |
| 2025-06-10 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-25-021995 ↗ |
| 2026-02-09 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-26-000494 ↗ |
| 2026-05-22 | S-1 | S-1 (registration) | Nuwellis, Inc. | 0001140361-26-022629 ↗ |
| 2026-05-29 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-26-023354 ↗ |
| 2026-06-04 | S-1/A | S-1/A (amendment) | Nuwellis, Inc. | 0001140361-26-023964 ↗ |
| 2026-06-04 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-26-001889 ↗ |
| 2026-06-05 | S-1MEF | S-1MEF (added securities) | Nuwellis, Inc. | 0001140361-26-024103 ↗ |
| 2026-06-08 | 424B4 | 424B4 (final prospectus) | Nuwellis, Inc. | 0001140361-26-024372 ↗ |
| 2026-08-26 | EFFECT | EFFECT (declared effective) | Nuwellis, Inc. | 9999999995-26-002772 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Bassett Kevin | Officer | Senior VP, Tech & Operations; VP Research, Development | 11 | 2012–2014 | |
| Brooke Geoffrey | Director | 3 | 2012–2014 | ||
| Callinan Nicholas | Director | 3 | 2012 | ||
| Harvey Mark | Director | 2 | 2012 | ||
| Kridner Debra | Officer | Exec VP, Regulatory Affairs; VP Clinical Research | 30 | 2012–2015 | |
| MATHIESEN JEFFREY S | Officer | Chief Financial Officer | 19 | 2012–2015 | |
| O'Dwyer Donal | Director | 4 | 2012 | ||
| Peters William S | Director,Officer; Officer | Chief Technical Officer; CTO and Medical Director; CTO & Medical Director | 23 | 2012–2015 | |
| Rosa David A | Director,Officer | Chief Executive Officer | 26 | 2012–2015 | |
| WALLER GREGORY D | Director | 16 | 2012–2026 | ||
| Yearick Jim | Officer | VP of Marketing and Sales | 11 | 2012–2014 | |
| BUCKMAN PAUL | Director | 7 | 2012–2016 | ||
| STRAUS ASSET MANAGEMENT, LLC | TenPercentOwner | 8 | 2012–2013 | ||
| STRAUS MELVILLE | TenPercentOwner | 8 | 2012–2013 | ||
| CM Capital | TenPercentOwner | 2 | 2012 | ||
| CM Capital Venture 4A A/C | TenPercentOwner | 3 | 2012–2014 | ||
| CM Capital Venture 4B A/C | TenPercentOwner | 3 | 2012–2014 | ||
| GBS Bioventures II A/C | TenPercentOwner | 1 | 2012 | ||
| GBS Bioventures III A/C | TenPercentOwner | 1 | 2012 | ||
| GBS Venture Partners Pty, Ltd | TenPercentOwner | 1 | 2012 | ||
| ERB JOHN L | Director; Director,Officer; Director,Officer,TenPercentOwner | CEO and President; CEO & President; Chairman of the Board | 19 | 2012–2025 | |
| WATSON WARREN S | Director | 13 | 2013–2023 | person page Fuzzy | |
| Salveson Jon W | Director | 13 | 2013–2023 | ||
| Verta Patrick | Officer | Chief Medical Officer | 2 | 2013 | |
| Oleson Kimberly | Officer | SVP, Clinical Affairs | 13 | 2014–2015 | |
| Brown Brian | Officer | SVP, Technology & Operations | 4 | 2014–2015 | |
| Talu Ventures Pty Ltd | TenPercentOwner | 1 | 2014 | ||
| Drayton Claudia | Officer | Chief Financial Officer | 20 | 2015–2021 | |
| Wade Molly | Officer | Vice President | 22 | 2015–2017 | |
| Lovett Eric | Officer | VP, Clinical Affairs | 2 | 2016 | |
| Brandt Steven Frank | Director | 10 | 2017–2022 | ||
| Likens Matthew E. | Director | 6 | 2017–2019 | ||
| Choi Ki Yong | TenPercentOwner | 4 | 2017 | ||
| Breidenstein Jim | Officer | Chief Commercial Officer | 3 | 2017–2018 | |
| Jaramillo Nestor Jr. | Director,Officer; Officer | Chief Commercial Officer; Chief Executive Officer; President and CEO | 7 | 2019–2023 | |
| Costanzo Maria Rosa | Director | 3 | 2019–2020 | ||
| Lynch Thomas P. | Officer | Chief Legal Compliance Officer; Chief Legal/Compliance Officer | 2 | 2020–2021 | |
| Wotta Paul | Officer | Principal Accounting Officer | 1 | 2021 | |
| AYOTTE NEIL P | Officer | SVP, Secretary, GC & CCO | 5 | 2021–2023 | |
| Montague George | Officer | CFO and Treasurer | 3 | 2021–2022 | |
| Blake Lynn Larson | Officer | Chief Financial Officer | 2 | 2022–2023 | |
| McCormick Michael Kendrick | Director; Director,Officer | President and CEO | 5 | 2023–2026 | |
| Scott Robert Benjamin | Officer | Chief Financial Officer | 2 | 2023 | |
| Feldshon Archelle Georgiou | Director | 4 | 2023–2026 | ||
| McDonald David | Director | 5 | 2023–2026 | ||
| Field Katharyn | Director | 1 | 2026 | ||
| Grasso Mika | Director | 1 | 2026 | ||
| Schultz Carisa | Officer | Chief Financial Officer | 1 | 2026 | |
| Emerson Martin J | Director | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2024-11-20 | Nuwellis, Inc. | Other Health Care | $3,848,286 | $3,848,286 | 9 | 1 |
| 2024-09-04 | Nuwellis, Inc. | Other Health Care | Indefinite | $0 | 6 | 1 |
| 2024-08-02 | Nuwellis, Inc. | Other Health Care | Indefinite | $0 | 7 | 1 |
| 2023-06-26 | Nuwellis, Inc. | Biotechnology | Indefinite | $0 | 1 | 1 |
| 2020-05-07 | CHF Solutions, Inc. | Biotechnology | $1,699,998 | $1,699,998 | 4 | 1 |
| 2020-04-08 | CHF Solutions, Inc. | Biotechnology | $2,226,519 | $2,226,519 | 4 | 1 |
| 2020-03-30 | CHF Solutions, Inc. | Biotechnology | $1,248,418 | $1,248,418 | 4 | 1 |
| 2019-11-21 | CHF Solutions, Inc. | Biotechnology | $1,365,300 | $1,365,300 | 3 | 1 |
| 2019-11-01 | CHF Solutions, Inc. | Biotechnology | $663,000 | $663,000 | 2 | 1 |
| 2017-02-27 | Sunshine Heart, Inc. | Biotechnology | $4,650,722 | $563,863 | 2 | 1 |
| 2017-01-25 | Sunshine Heart, Inc. | Biotechnology | $200,000 | $200,000 | 2 | 1 |
| 2016-11-09 | Sunshine Heart, Inc. | Biotechnology | $3,600,000 | $3,600,000 | 2 | 1 |
| 2016-08-18 | Sunshine Heart, Inc. | Biotechnology | $950,000 | $950,000 | 1 | 1 |
| 2016-08-02 | Sunshine Heart, Inc. | Biotechnology | $3,468,000 | $3,468,000 | 2 | 1 |
| 2015-03-02 | Sunshine Heart, Inc. | Biotechnology | $600,000 | $360,000 | 2 | 1 |
| 2012-02-22 | Sunshine Heart, Inc. | Biotechnology | Indefinite | $2,112,769 | 4 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.